{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:55:28Z","timestamp":1790758528784,"version":"4.1.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41569-019-0284-0","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T15:04:31Z","timestamp":1570806271000},"page":"286-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":204,"title":["Genetics of dilated cardiomyopathy: practical implications for heart failure management"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9202-0233","authenticated-orcid":false,"given":"Andrew N.","family":"Rosenbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6202-2112","authenticated-orcid":false,"given":"Katherine E.","family":"Agre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen L.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"key":"284_CR1","first-page":"e38","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian, D. et al. Heart disease and stroke statistics \u2014 2016 update a report from the American Heart Association. Circulation 133, e38\u2013e360 (2016).","journal-title":"Circulation"},{"key":"284_CR2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","volume":"8","author":"AL Bui","year":"2011","unstructured":"Bui, A. L., Horwich, T. B. & Fonarow, G. C. Epidemiology and risk profile of heart failure. Nat. Rev. Cardiol. 8, 30\u201341 (2011).","journal-title":"Nat. Rev. Cardiol."},{"key":"284_CR3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ehf2.12005","volume":"1","author":"P Ponikowski","year":"2014","unstructured":"Ponikowski, P. et al. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 1, 4\u201325 (2014).","journal-title":"ESC Heart Fail."},{"key":"284_CR4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","volume":"175","author":"Y Gerber","year":"2015","unstructured":"Gerber, Y. et al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern. Med. 175, 996\u20131004 (2015).","journal-title":"JAMA Intern. Med."},{"key":"284_CR5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","volume":"6","author":"PA Heidenreich","year":"2013","unstructured":"Heidenreich, P. A. et al. Forecasting the impact of heart failure in the United States a policy statement from the American Heart Association. Circ. Heart Fail. 6, 606\u2013619 (2013).","journal-title":"Circ. Heart Fail."},{"key":"284_CR6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","volume":"289","author":"MM Redfield","year":"2003","unstructured":"Redfield, M. M. et al. Burden of systolic and diastolic ventricular dysfunction in the community. JAMA 289, 194 (2003).","journal-title":"JAMA"},{"key":"284_CR7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","volume":"10","author":"RE Hershberger","year":"2013","unstructured":"Hershberger, R. E., Hedges, D. J. & Morales, A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat. Rev. Cardiol. 10, 531\u2013547 (2013).","journal-title":"Nat. Rev. Cardiol."},{"key":"284_CR8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mhj.2002.121264","volume":"143","author":"S Baldasseroni","year":"2002","unstructured":"Baldasseroni, S. et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian Network on Congestive Heart Failure. Am. Heart J. 143, 398\u2013405 (2002).","journal-title":"Am. Heart J."},{"key":"284_CR9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCRESAHA.113.300282","volume":"113","author":"TJ Cahill","year":"2013","unstructured":"Cahill, T. J., Ashrafian, H. & Watkins, H. Genetic cardiomyopathies causing heart failure. Circ. Res. 113, 660\u2013675 (2013).","journal-title":"Circ. Res."},{"key":"284_CR10","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jacc.2011.01.015","volume":"57","author":"EL Burkett","year":"2011","unstructured":"Burkett, E. L. & Hershberger, R. E. Clinical and genetic issues in familial dilated cardiomyopathy. J. Am. Coll. Cardiol. 57, 1641\u20131649 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(09)62023-7","volume":"375","author":"JL Jefferies","year":"2010","unstructured":"Jefferies, J. L. & Towbin, J. A. Dilated cardiomyopathy. Lancet 375, 752\u2013762 (2010).","journal-title":"Lancet"},{"key":"284_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199201093260201","volume":"326","author":"V Michels","year":"1992","unstructured":"Michels, V. et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N. Engl. J. Med. 326, 77\u201382 (1992).","journal-title":"N. Engl. J. Med."},{"key":"284_CR13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0735-1097(97)00434-8","volume":"31","author":"E Gr\u00fcnig","year":"1998","unstructured":"Gr\u00fcnig, E. et al. Frequency and phenotypes of familial dilated cardiomyopathy. J. Am. Coll. Cardiol. 31, 186\u2013194 (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","volume":"121","author":"EM McNally","year":"2017","unstructured":"McNally, E. M. & Mestroni, L. Dilated cardiomyopathy: genetic determinants and mechanisms. Circ. Res. 121, 731\u2013748 (2017).","journal-title":"Circ. Res."},{"key":"284_CR15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11936-019-0742-3","volume":"21","author":"AN Rosenbaum","year":"2019","unstructured":"Rosenbaum, A. N. & Pereira, N. L. Updates on the genetic paradigm in heart failure. Curr. Treat. Options Cardiovasc. Med. 21, 37 (2019).","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"284_CR16","doi-asserted-by":"crossref","unstructured":"Briasoulis, A., Asleh, R. & Pereira, N. in Encyclopedia of Cardiovascular Research and Medicine 1st edn (eds Sawyer, D. & Vasan, R.) 368\u2013379 (Elsevier, 2018).","DOI":"10.1016\/B978-0-12-809657-4.10900-7"},{"key":"284_CR17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/heart.84.1.106","volume":"84","author":"P Elliott","year":"2000","unstructured":"Elliott, P. Cardiomyopathy: diagnosis and management of dilated cardiomyopathy. Heart 84, 106\u2013106 (2000).","journal-title":"Heart"},{"key":"284_CR18","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","volume":"67","author":"AG Japp","year":"2016","unstructured":"Japp, A. G., Gulati, A., Cook, S. A., Cowie, M. R. & Prasad, S. K. The diagnosis and evaluation of dilated cardiomyopathy. J. Am. Coll. Cardiol. 67, 2996\u20133010 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1517\/21678707.2015.1057498","volume":"3","author":"ME Sweet","year":"2015","unstructured":"Sweet, M. E., Taylor, M. R. & Mestroni, L. Diagnosis, prevalence, and screening of familial dilated cardiomyopathy. Expert. Opin. Orphan Drugs 3, 869\u2013876 (2015).","journal-title":"Expert. Opin. Orphan Drugs"},{"key":"284_CR20","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Am. Coll. Med. Genet. Genomics 17, 405\u2013424 (2015).","journal-title":"Am. Coll. Med. Genet. Genomics"},{"key":"284_CR21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2009.05.009","volume":"54","author":"S Cresci","year":"2009","unstructured":"Cresci, S. et al. Clinical and genetic modifiers of long-term survival in heart failure. J. Am. Coll. Cardiol. 54, 432\u2013444 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nrg1470","volume":"5","author":"C-C Liew","year":"2004","unstructured":"Liew, C.-C. & Dzau, V. J. Molecular genetics and genomics of heart failure. Nat. Rev. Genet. 5, 811\u2013825 (2004).","journal-title":"Nat. Rev. Genet."},{"key":"284_CR23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ejhf.255","volume":"17","author":"M Harakalova","year":"2015","unstructured":"Harakalova, M. et al. A systematic analysis of genetic dilated cardiomyopathy reveals numerous ubiquitously expressed and muscle-specific genes. Eur. J. Heart Fail. 17, 484\u2013493 (2015).","journal-title":"Eur. J. Heart Fail."},{"key":"284_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-017-0410-8","volume":"9","author":"U Tayal","year":"2017","unstructured":"Tayal, U., Prasad, S. & Cook, S. A. Genetics and genomics of dilated cardiomyopathy and systolic heart failure. Genome Med. 9, 1\u201314 (2017).","journal-title":"Genome Med."},{"key":"284_CR25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","volume":"20","author":"RE Hershberger","year":"2018","unstructured":"Hershberger, R. E. et al. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 20, 899\u2013909 (2018).","journal-title":"Genet. Med."},{"key":"284_CR26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cardfail.2012.01.013","volume":"18","author":"NK Lakdawala","year":"2012","unstructured":"Lakdawala, N. K. et al. Genetic testing for dilated cardiomyopathy in clinical practice. J. Card. Fail. 18, 296\u2013303 (2012).","journal-title":"J. Card. Fail."},{"key":"284_CR27","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1161\/01.cir.0000437913.98912.1d","volume":"128","author":"SK Ganesh","year":"2013","unstructured":"Ganesh, S. K. et al. Genetics and genomics for the prevention and treatment of cardiovascular disease: update. a scientific statement from the American Heart Association. Circulation 128, 2813\u20132851 (2013).","journal-title":"Circulation"},{"key":"284_CR28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/gim.2013.204","volume":"16","author":"TJ Pugh","year":"2014","unstructured":"Pugh, T. J. et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet. Med. 16, 601\u2013608 (2014).","journal-title":"Genet. Med."},{"key":"284_CR29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","volume":"24","author":"RE Hershberger","year":"2009","unstructured":"Hershberger, R. E. et al. Genetic evaluation of cardiomyopathy\u2014a Heart Failure Society of America practice guideline. J. Card. Fail. 24, 281\u2013302 (2009).","journal-title":"J. Card. Fail."},{"key":"284_CR30","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMra1711801","volume":"379","author":"DR Adams","year":"2018","unstructured":"Adams, D. R. & Eng, C. M. Next-generation sequencing to diagnose suspected genetic disorders. N. Engl. J. Med. 379, 1353\u20131362 (2018).","journal-title":"N. Engl. J. Med."},{"key":"284_CR31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM199701233360407","volume":"336","author":"SS Kushwaha","year":"1997","unstructured":"Kushwaha, S. S., Fallon, J. T. & Fuster, V. Restrictive cardiomyopathy. N. Engl. J. Med. 336, 267\u2013276 (1997).","journal-title":"N. Engl. J. Med."},{"key":"284_CR32","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00246-008-9359-0","volume":"30","author":"J Finsterer","year":"2009","unstructured":"Finsterer, J. Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation\/noncompaction. Pediatr. Cardiol. 30, 659\u2013681 (2009).","journal-title":"Pediatr. Cardiol."},{"key":"284_CR33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(14)61282-4","volume":"386","author":"JA Towbin","year":"2015","unstructured":"Towbin, J. A., Lorts, A. & Jefferies, J. L. Left ventricular non-compaction cardiomyopathy. Lancet 386, 813\u2013825 (2015).","journal-title":"Lancet"},{"key":"284_CR34","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1016\/j.jacc.2016.04.024","volume":"67","author":"M Gallego-Delgado","year":"2016","unstructured":"Gallego-Delgado, M. et al. Idiopathic restrictive cardiomyopathy is primarily a genetic disease. J. Am. Coll. Cardiol. 67, 3021\u20133023 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR35","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","volume":"36","author":"J Haas","year":"2015","unstructured":"Haas, J. et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur. Heart J. 36, 1123\u20131135 (2015).","journal-title":"Eur. Heart J."},{"key":"284_CR36","doi-asserted-by":"crossref","unstructured":"Bennett, R. L. The Practical Guide to the Genetic Family History 2nd edn (Wiley, 2010).","DOI":"10.1002\/9780470568248"},{"key":"284_CR37","first-page":"355","volume":"8","author":"E Arbustini","year":"2013","unstructured":"Arbustini, E. et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the world heart federation. Glob. Heart 8, 355\u2013382 (2013).","journal-title":"Heart"},{"key":"284_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1172\/JCI62862","volume":"123","author":"EM Mcnally","year":"2013","unstructured":"Mcnally, E. M., Golbus, J. R. & Puckelwartz, M. J. Genetic mutations and mechanisms in dilated cardiomyopathy. J. Clin. Invest. 123, 19\u201326 (2013).","journal-title":"J. Clin. Invest."},{"key":"284_CR39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0735-1097(97)00433-6","volume":"31","author":"MK Baig","year":"1998","unstructured":"Baig, M. K. et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relative and may represent early disease. J. Am. Coll. Cardiol. 31, 195\u2013201 (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR40","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy, C. W. et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. J. Am. Coll. Cardiol. 62, e147\u2013e239 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR41","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/eurheartj\/ehq271","volume":"31","author":"P Charron","year":"2010","unstructured":"Charron, P. et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 31, 2715\u20132728 (2010).","journal-title":"Eur. Heart J."},{"key":"284_CR42","first-page":"e579","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt, B. et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation 134, e579\u2013e646 (2016).","journal-title":"Circulation"},{"key":"284_CR43","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","volume":"8","author":"MJ Ackerman","year":"2011","unstructured":"Ackerman, M. J. et al. HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 8, 1308\u20131339 (2011).","journal-title":"Heart Rhythm."},{"key":"284_CR44","doi-asserted-by":"publisher","unstructured":"Towbin, J. A. et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm \nhttps:\/\/doi.org\/10.1016\/j.hrthm.2019.05.007\n\n (2019).","DOI":"10.1016\/j.hrthm.2019.05.007"},{"key":"284_CR45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/jmg.2004.023283","volume":"42","author":"N Sylvius","year":"2005","unstructured":"Sylvius, N. et al. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J. Med. Genet. 42, 639\u2013647 (2005).","journal-title":"J. Med. Genet."},{"key":"284_CR46","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","volume":"341","author":"D Fatkin","year":"1999","unstructured":"Fatkin, D. et al. Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease. N. Engl. J. Med. 341, 1715\u20131724 (1999).","journal-title":"N. Engl. J. Med."},{"key":"284_CR47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00109-004-0589-1","volume":"83","author":"JH van Berlo","year":"2004","unstructured":"van Berlo, J. H. et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A\/C mutations portend a high risk of sudden death? J. Mol. Med. 83, 79\u201383 (2004).","journal-title":"J. Mol. Med."},{"key":"284_CR48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ahj.2008.01.026","volume":"156","author":"SB Parks","year":"2008","unstructured":"Parks, S. B. et al. Lamin A\/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am. Heart J. 156, 161\u2013169 (2008).","journal-title":"Am. Heart J."},{"key":"284_CR49","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ahj.2007.07.038","volume":"154","author":"JP van Tintelen","year":"2007","unstructured":"van Tintelen, J. P. et al. High yield of LMNA mutations in patients with dilated cardiomyopathy and\/or conduction disease referred to cardiogenetics outpatient clinics. Am. Heart J. 154, 1130\u20131139 (2007).","journal-title":"Am. Heart J."},{"key":"284_CR50","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1172\/JCI24351","volume":"115","author":"H Morita","year":"2005","unstructured":"Morita, H., Seidman, J. G. & Seidman, C. E. Genetic causes of human heart failure. J. Clin. Invest. 115, 518\u2013526 (2005).","journal-title":"J. Clin. Invest."},{"key":"284_CR51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13675-8","volume":"7","author":"PG Vikhorev","year":"2017","unstructured":"Vikhorev, P. G. et al. Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes. Sci. Rep. 7, 14829 (2017).","journal-title":"Sci. Rep."},{"key":"284_CR52","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.yjmcc.2009.04.014","volume":"47","author":"M Gramlich","year":"2009","unstructured":"Gramlich, M. et al. Stress-induced dilated cardiomyopathy in a knock-in mouse model mimicking human titin-based disease. J. Mol. Cell. Cardiol. 47, 352\u2013358 (2009).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"284_CR53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng815","volume":"30","author":"B Gerull","year":"2002","unstructured":"Gerull, B. et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat. Genet. 30, 201\u2013204 (2002).","journal-title":"Nat. Genet."},{"key":"284_CR54","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","volume":"366","author":"DS Herman","year":"2012","unstructured":"Herman, D. S. et al. Truncations of titin causing dilated cardiomyopathy. N. Engl. J. Med. 366, 619\u2013628 (2012).","journal-title":"N. Engl. J. Med."},{"key":"284_CR55","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.jacc.2017.08.063","volume":"70","author":"U Tayal","year":"2017","unstructured":"Tayal, U. et al. Phenotype and clinical outcomes of titin cardiomyopathy. J. Am. Coll. Cardiol. 70, 2264\u20132274 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR56","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.673","volume":"19","author":"JA Jansweijer","year":"2017","unstructured":"Jansweijer, J. A. et al. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy. Eur. J. Heart Fail. 19, 512\u2013521 (2017).","journal-title":"Eur. J. Heart Fail."},{"key":"284_CR57","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(16)31321-6","volume":"389","author":"J Veselka","year":"2017","unstructured":"Veselka, J., Anavekar, N. S. & Charron, P. Hypertrophic obstructive cardiomyopathy. Lancet 389, 1253\u20131267 (2017).","journal-title":"Lancet"},{"key":"284_CR58","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jacc.2004.05.088","volume":"44","author":"J Mogensen","year":"2004","unstructured":"Mogensen, J. et al. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44, 2315\u20132325 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0735-1097(96)00530-X","volume":"29","author":"JC Moolman","year":"1997","unstructured":"Moolman, J. C. et al. Sudden death due to troponin T mutations. J. Am. Coll. Cardiol. 29, 549\u2013555 (1997).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR60","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","volume":"332","author":"H Watkins","year":"1995","unstructured":"Watkins, H. et al. Mutations in the genes for cardiac troponin t and \u03b1-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332, 1058\u20131064 (1995).","journal-title":"N. Engl. J. Med."},{"key":"284_CR61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9149(01)02158-0","volume":"89","author":"N Fujino","year":"2002","unstructured":"Fujino, N. et al. A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy. Am. J. Cardiol. 89, 29\u201333 (2002).","journal-title":"Am. J. Cardiol."},{"key":"284_CR62","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.CIR.102.6.663","volume":"102","author":"H Kokado","year":"2000","unstructured":"Kokado, H. et al. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation 102, 663\u2013669 (2000).","journal-title":"Circulation"},{"key":"284_CR63","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1161\/01.CIR.102.17.e112","volume":"102","author":"V Regitz-Zagrosek","year":"2000","unstructured":"Regitz-Zagrosek, V., Erdmann, J., Wellnhofer, E., Raible, J. & Fleck, E. Novel mutation in the \u03b1-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy. Circulation 102, e112\u2013e116 (2000).","journal-title":"Circulation"},{"key":"284_CR64","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200012073432304","volume":"343","author":"M Kamisago","year":"2000","unstructured":"Kamisago, M. et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N. Engl. J. Med. 343, 1688\u20131696 (2000).","journal-title":"N. Engl. J. Med."},{"key":"284_CR65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0006-291X(02)02374-4","volume":"298","author":"S Daehmlow","year":"2002","unstructured":"Daehmlow, S. et al. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 298, 116\u2013120 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"284_CR66","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jacc.2009.12.016","volume":"55","author":"JM Bos","year":"2010","unstructured":"Bos, J. M. & Ackerman, M. J. Z-disc genes in hypertrophic cardiomyopathy: stretching the cardiomyopathies? J. Am. Coll. Cardiol. 55, 1136\u20131138 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR67","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0092-8674(02)01226-6","volume":"111","author":"R Kn\u00f6ll","year":"2002","unstructured":"Kn\u00f6ll, R. et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111, 943\u2013955 (2002).","journal-title":"Cell"},{"key":"284_CR68","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/hc0402.102930","volume":"105","author":"TM Olson","year":"2002","unstructured":"Olson, T. M. et al. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 105, 431\u2013437 (2002).","journal-title":"Circulation"},{"key":"284_CR69","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/eurheartj\/ehi193","volume":"26","author":"E Villard","year":"2005","unstructured":"Villard, E. et al. Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur. Heart J. 26, 794\u2013803 (2005).","journal-title":"Eur. Heart J."},{"key":"284_CR70","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/cvr\/cvm015","volume":"77","author":"L Duboscq-Bidot","year":"2008","unstructured":"Duboscq-Bidot, L. et al. Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy. Cardiovasc. Res. 77, 118\u2013125 (2008).","journal-title":"Cardiovasc. Res."},{"key":"284_CR71","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM200003163421104","volume":"342","author":"M Dalakas","year":"2000","unstructured":"Dalakas, M. et al. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N. Engl. J. Med. 342, 770\u2013780 (2000).","journal-title":"N. Engl. J. Med."},{"key":"284_CR72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.CIR.100.5.461","volume":"100","author":"D Li","year":"1999","unstructured":"Li, D. et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100, 461\u2013464 (1999).","journal-title":"Circulation"},{"key":"284_CR73","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejheart.2005.11.003","volume":"8","author":"E Arbustini","year":"2006","unstructured":"Arbustini, E. et al. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects. Eur. J. Heart Fail. 8, 477\u2013483 (2006).","journal-title":"Eur. J. Heart Fail."},{"key":"284_CR74","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jacbts.2016.05.004","volume":"1","author":"RL Begay","year":"2016","unstructured":"Begay, R. L. et al. FLNC gene splice mutations cause dilated cardiomyopathy. JACC Basic Transl. Sci. 1, 344\u2013359 (2016).","journal-title":"JACC Basic Transl. Sci."},{"key":"284_CR75","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","volume":"68","author":"MF Ortiz-Genga","year":"2016","unstructured":"Ortiz-Genga, M. F. et al. Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies. J. Am. Coll. Cardiol. 68, 2440\u20132451 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR76","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacep.2017.12.003","volume":"4","author":"RL Begay","year":"2018","unstructured":"Begay, R. L. et al. Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell\u2013cell adhesion structures. JACC Clin. Electrophysiol. 4, 504\u2013514 (2018).","journal-title":"JACC Clin. Electrophysiol."},{"key":"284_CR77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ana.21553","volume":"65","author":"D Selcen","year":"2009","unstructured":"Selcen, D. et al. Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann. Neurol. 65, 83\u201389 (2009).","journal-title":"Ann. Neurol."},{"key":"284_CR78","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCGENETICS.110.937805","volume":"3","author":"P Elliott","year":"2010","unstructured":"Elliott, P. et al. Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy. Circ. Cardiovasc. Genet. 3, 314\u2013322 (2010).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"284_CR79","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/hrt.2011.227967","volume":"97","author":"P Garcia-Pavia","year":"2011","unstructured":"Garcia-Pavia, P. et al. Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study. Heart 97, 1744\u20131752 (2011).","journal-title":"Heart"},{"key":"284_CR80","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/01.CIR.103.9.1256","volume":"103","author":"F Ichida","year":"2001","unstructured":"Ichida, F. et al. Novel gene mutations in patients with left ventricular noncompaction or barth syndrome. Circulation 103, 1256\u20131263 (2001).","journal-title":"Circulation"},{"key":"284_CR81","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijcard.2009.07.003","volume":"140","author":"G Captur","year":"2010","unstructured":"Captur, G. & Nihoyannopoulos, P. Left ventricular non-compaction: genetic heterogeneity, diagnosis and clinical course. Int. J. Cardiol. 140, 145\u2013153 (2010).","journal-title":"Int. J. Cardiol."},{"key":"284_CR82","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/514886","volume":"61","author":"P D\u2019Adamo","year":"1997","unstructured":"D\u2019Adamo, P. et al. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am. J. Hum. Genet. 61, 862\u2013867 (1997).","journal-title":"Am. J. Hum. Genet."},{"key":"284_CR83","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ng0496-385","volume":"12","author":"S Bione","year":"1996","unstructured":"Bione, S. et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat. Genet. 12, 385\u2013389 (1996).","journal-title":"Nat. Genet."},{"key":"284_CR84","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jacc.2009.05.038","volume":"54","author":"KM Brauch","year":"2009","unstructured":"Brauch, K. M. et al. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J. Am. Coll. Cardiol. 54, 930\u2013941 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR85","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.117.031947","volume":"138","author":"MMG van den Hoogenhof","year":"2018","unstructured":"van den Hoogenhof, M. M. G. et al. RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling. Circulation 138, 1330\u20131342 (2018).","journal-title":"Circulation"},{"key":"284_CR86","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jama.293.4.447","volume":"293","author":"TM Olson","year":"2005","unstructured":"Olson, T. M. et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293, 447\u2013454 (2005).","journal-title":"JAMA"},{"key":"284_CR87","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.0000144458.58660.BB","volume":"110","author":"WP McNair","year":"2004","unstructured":"McNair, W. P. et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 110, 2163\u20132167 (2004).","journal-title":"Circulation"},{"key":"284_CR88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mnc.2001.112755","volume":"8","author":"A Brega","year":"2001","unstructured":"Brega, A., Narula, J. & Arbustini, E. Functional, structural, and genetic mitochondrial abnormalities in myocardial diseases. J. Nucl. Cardiol. 8, 89\u201397 (2001).","journal-title":"J. Nucl. Cardiol."},{"key":"284_CR89","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ejhg.2010.169","volume":"19","author":"MV Zaragoza","year":"2011","unstructured":"Zaragoza, M. V., Brandon, M. C., Diegoli, M., Arbustini,\u00a0E. & Wallace, D. C. Mitochondrial cardiomyopathies: how to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny. Eur. J. Hum. Genet. 19, 200\u2013207 (2011).","journal-title":"Eur. J. Hum. Genet."},{"key":"284_CR90","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.91.4.955","volume":"91","author":"R Anan","year":"1995","unstructured":"Anan, R. et al. Cardiac involvement in mitochondrial diseases: a study on 17 patients with documented mitochondrial DNA defects. Circulation 91, 955\u2013961 (1995).","journal-title":"Circulation"},{"key":"284_CR91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.carpath.2018.11.002","volume":"39","author":"V Nair","year":"2019","unstructured":"Nair, V., Belanger, E. C. & Veinot, J. P. Lysosomal storage disorders affecting the heart: a review. Cardiovasc. Pathol. 39, 12\u201324 (2019).","journal-title":"Cardiovasc. Pathol."},{"key":"284_CR92","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","volume":"67","author":"F Kamdar","year":"2016","unstructured":"Kamdar, F. & Garry, D. J. Dystrophin-deficient cardiomyopathy. J. Am. Coll. Cardiol. 67, 2533\u20132546 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR93","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/01.CIR.87.6.1854","volume":"87","author":"JA Towbin","year":"1993","unstructured":"Towbin, J. A. et al. X-linked dilated cardiomyopathy - molecular-genetic evidence of linkage to the Duchenne muscular-dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87, 1854\u20131865 (1993).","journal-title":"Circulation"},{"key":"284_CR94","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1050-1738(01)00126-8","volume":"11","author":"LC Mounkes","year":"2001","unstructured":"Mounkes, L. C., Burke, B. & Stewart, C. L. The A-type lamins: nuclear structural proteins as a focus for muscular dystrophy and cardiovascular diseases. Trends Cardiovasc. Med. 11, 280\u2013285 (2001).","journal-title":"Trends Cardiovasc. Med."},{"key":"284_CR95","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/6799","volume":"21","author":"G Bonne","year":"1999","unstructured":"Bonne, G. et al. Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 21, 285\u2013288 (1999).","journal-title":"Nat. Genet."},{"key":"284_CR96","first-page":"1","volume":"33","author":"V Nigro","year":"2014","unstructured":"Nigro, V. & Savarese, M. Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol. 33, 1\u201312 (2014).","journal-title":"Acta Myol."},{"key":"284_CR97","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/euhj.1998.1145","volume":"20","author":"L Mestroni","year":"1999","unstructured":"Mestroni, L. et al. Guidelines for the study of familial dilated cardiomyopathies. Eur. Heart J. 20, 93\u2013102 (1999).","journal-title":"Eur. Heart J."},{"key":"284_CR98","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/gim.2014.122","volume":"17","author":"Y Xue","year":"2015","unstructured":"Xue, Y., Ankala, A., Wilcox, W. R. & Hegde, M. R. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome\/genome sequencing. Genet. Med. 17, 444\u2013451 (2015).","journal-title":"Genet. Med."},{"key":"284_CR99","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa1306555","volume":"369","author":"Y Yang","year":"2013","unstructured":"Yang, Y. et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 369, 1502\u20131511 (2013).","journal-title":"N. Engl. J. Med."},{"key":"284_CR100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jacc.2018.04.078","volume":"72","author":"RD Bagnall","year":"2018","unstructured":"Bagnall, R. D. et al. Whole genome sequencing improves outcomes of genetic testing in patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 72, 419\u2013429 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR101","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1056\/NEJMra1312543","volume":"370","author":"LG Biesecker","year":"2014","unstructured":"Biesecker, L. G. & Green, R. C. Diagnostic clinical genome and exome sequencing. N. Engl. J. Med. 370, 2418\u20132425 (2014).","journal-title":"N. Engl. J. Med."},{"key":"284_CR102","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001442","volume":"10","author":"S Mohammed","year":"2017","unstructured":"Mohammed, S. et al. Genetic insurance discrimination in sudden arrhythmia death syndromes empirical evidence from a cross-sectional survey in North America. Circ. Cardiovasc. Genet. 10, e001442 (2017).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"284_CR103","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14636778.2010.528189","volume":"29","author":"Y Joly","year":"2010","unstructured":"Joly, Y., Braker, M. & Le Huynh, M. Genetic discrimination in private insurance: global perspectives. New Genet. Soc. 29, 351\u2013368 (2010).","journal-title":"New Genet. Soc."},{"key":"284_CR104","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/gim.2017.212","volume":"20","author":"A Bland","year":"2018","unstructured":"Bland, A. et al. Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience. Genet. Med. 20, 369\u2013373 (2018).","journal-title":"Genet. Med."},{"key":"284_CR105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajhg.2016.06.001","volume":"99","author":"LM Amendola","year":"2016","unstructured":"Amendola, L. M. et al. Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the clinical sequencing exploratory research consortium. Am. J. Hum. Genet. 99, 247 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"284_CR106","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/gim.2017.14","volume":"19","author":"SM Harrison","year":"2017","unstructured":"Harrison, S. M. et al. Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVar. Genet. Med. 19, 1096\u20131104 (2017).","journal-title":"Genet. Med."},{"key":"284_CR107","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/gim.2017.218","volume":"20","author":"MA Kelly","year":"2018","unstructured":"Kelly, M. A. et al. Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen\u2019s Inherited Cardiomyopathy Expert Panel. Genet. Med. 20, 351\u2013359 (2018).","journal-title":"Genet. Med."},{"key":"284_CR108","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jlb\/lsx038","volume":"4","author":"L Hoffman-Andrews","year":"2017","unstructured":"Hoffman-Andrews, L. The known unknown: the challenges of genetic variants of uncertain significance in clinical practice. J. Law Biosci. 4, 648\u2013657 (2017).","journal-title":"J. Law Biosci."},{"key":"284_CR109","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1161\/CIRCULATIONAHA.118.035028","volume":"138","author":"W Lv","year":"2018","unstructured":"Lv, W. et al. Functional annotation of TNNT2 variants of uncertain significance with genome-edited cardiomyocytes. Circulation 138, 2852\u20132854 (2018).","journal-title":"Circulation"},{"key":"284_CR110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001167","volume":"6","author":"K Stark","year":"2010","unstructured":"Stark, K. et al. Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy. PLOS Genet. 6, e1001167 (2010).","journal-title":"PLOS Genet."},{"key":"284_CR111","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/eurheartj\/ehr105","volume":"32","author":"E Villard","year":"2011","unstructured":"Villard, E. et al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur. Heart J. 32, 1065\u20131076 (2011).","journal-title":"Eur. Heart J."},{"key":"284_CR112","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/CIRCGENETICS.109.898395","volume":"3","author":"TP Cappola","year":"2010","unstructured":"Cappola, T. P. et al. Common variants in HSPB7 and FRMD4B associated with advanced heart failure. Circ. Cardiovasc. Genet. 3, 147\u2013154 (2010).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"284_CR113","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/eurheartj\/eht251","volume":"35","author":"B Meder","year":"2014","unstructured":"Meder, B. et al. A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur. Heart J. 35, 1069\u20131077 (2014).","journal-title":"Eur. Heart J."},{"key":"284_CR114","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1073\/pnas.1017494108","volume":"108","author":"TP Cappola","year":"2011","unstructured":"Cappola, T. P. et al. Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation. Proc. Natl Acad. Sci. USA 108, 2456\u20132461 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"284_CR115","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-12-192","volume":"12","author":"M Franaszczyk","year":"2014","unstructured":"Franaszczyk, M. et al. The BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation. J. Transl Med. 12, 192 (2014).","journal-title":"J. Transl. Med."},{"key":"284_CR116","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1752-8062.2010.00251.x","volume":"4","author":"A Parsa","year":"2011","unstructured":"Parsa, A. et al. Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. Clin. Transl Sci. 4, 17\u201323 (2011).","journal-title":"Clin. Transl Sci."},{"key":"284_CR117","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/CIRCGENETICS.111.962365","volume":"6","author":"ER Fox","year":"2013","unstructured":"Fox, E. R. et al. Genome-wide association study of cardiac structure and systolic function in African Americans: the Candidate Gene Association Resource (CARe) study. Circ. Cardiovasc. Genet. 6, 37\u201346 (2013).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"284_CR118","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCGENETICS.109.895763","volume":"3","author":"NL Smith","year":"2010","unstructured":"Smith, N. L. et al. Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. Circ. Cardiovasc. Genet. 3, 256\u2013266 (2010).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"284_CR119","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMc052632","volume":"354","author":"C Meune","year":"2006","unstructured":"Meune, C. et al. Primary prevention of sudden death in patients with lamin A\/C gene mutations. N. Engl. J. Med. 354, 209\u2013210 (2006).","journal-title":"N. Engl. J. Med."},{"key":"284_CR120","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1046\/j.1460-9592.2000.01661.x","volume":"23","author":"HM B\u00e9cane","year":"2000","unstructured":"B\u00e9cane, H. M. et al. High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin. Electrophysiol. 23, 1661\u20131666 (2000).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"284_CR121","volume":"12","author":"JG Smith","year":"2016","unstructured":"Smith, J. G. et al. Discovery of genetic variation on chromosome 5q22 associated with mortality in heart failure. PLOS Genet. 12, e1006034 (2016).","journal-title":"PLOS Genet."},{"key":"284_CR122","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/CIRCGENETICS.109.895995","volume":"3","author":"AC Morrison","year":"2010","unstructured":"Morrison, A. C. et al. Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. Circ. Cardiovasc. Genet. 3, 248\u2013255 (2010).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"284_CR123","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/jamacardio.2018.2541","volume":"3","author":"VD Myers","year":"2018","unstructured":"Myers, V. D. et al. Association of variants in BAG3 with cardiomyopathy outcomes in African American individuals. JAMA Cardiol. 3, 929\u2013938 (2018).","journal-title":"JAMA Cardiol."},{"key":"284_CR124","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1073\/pnas.0509937103","volume":"103","author":"SB Liggett","year":"2006","unstructured":"Liggett, S. B. et al. A polymorphism within a conserved \u03b21-adrenergic receptor motif alters cardiac function and \u03b2-blocker response in human heart failure. Proc. Natl Acad. Sci. USA 103, 11288\u201311293 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"284_CR125","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.jacc.2005.08.041","volume":"46","author":"H Bruck","year":"2005","unstructured":"Bruck, H. et al. The Arg389Gly \u03b21-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity. J. Am. Coll. Cardiol. 46, 2111\u20132115 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01213011-200504000-00006","volume":"15","author":"SG Terra","year":"2005","unstructured":"Terra, S. G. et al. \u03b21-Adrenergic receptor polymorphisms and left ventricular remodeling changes in response to \u03b2-blocker therapy. Pharmacogenet. Genomics 15, 227\u2013234 (2005).","journal-title":"Pharmacogenet. Genomics"},{"key":"284_CR127","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/euhj.2001.3037","volume":"23","author":"H White","year":"2002","unstructured":"White, H. et al. An evaluation of the \u03b21 adrenergic receptor Arg389Gly polymorphism in individuals at risk of coronary events: a WOSCOPS substudy. Eur. Heart J. 23, 1087\u20131092 (2002).","journal-title":"Eur. Heart J."},{"key":"284_CR128","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1388-9842(03)00044-8","volume":"5","author":"HL White","year":"2003","unstructured":"White, H. L. et al. An evaluation of the \u03b21 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study. Eur. J. Heart Fail. 5, 463\u2013468 (2003).","journal-title":"Eur. J. Heart Fail."},{"key":"284_CR129","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1388-9842(99)00045-8","volume":"1","author":"B Andersson","year":"1999","unstructured":"Andersson, B., Blange, I., Sylven, C. & Sylv\u00e9n, C. Angiotensin-II type 1 receptor gene polymorphism and long-term survival in patients with idiopathic congestive heart failure. Eur. J. Heart Fail. 1, 363\u2013369 (1999).","journal-title":"Eur. J. Heart Fail."},{"key":"284_CR130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejheart.2003.09.004","volume":"6","author":"W Huang","year":"2004","unstructured":"Huang, W., Xie, C., Zhou, H., Yang, T. & Sun, M. Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients. Eur. J. Heart Fail. 6, 23\u201327 (2004).","journal-title":"Eur. J. Heart Fail."},{"key":"284_CR131","first-page":"1644","volume":"44","author":"DM McNamara","year":"2004","unstructured":"McNamara, D. M. et al. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. J. Am. Coll. Cardiol. 44, 1644\u20131649 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0144195","volume":"10","author":"KE Nelveg-Kristensen","year":"2015","unstructured":"Nelveg-Kristensen, K. E. et al. Pharmacogenetic risk stratification in angiotensin-converting enzyme inhibitor-treated patients with congestive heart failure: a retrospective cohort study. PLOS ONE 10, 1\u201316 (2015).","journal-title":"PLOS ONE"},{"key":"284_CR133","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/FPC.0b013e328363c137","volume":"23","author":"G Pare","year":"2013","unstructured":"Pare, G. et al. Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet. Genomics 23, 470\u2013478 (2013).","journal-title":"Pharmacogenet. Genomics"},{"key":"284_CR134","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nrcardio.2009.154","volume":"6","author":"NL Pereira","year":"2009","unstructured":"Pereira, N. L. & Weinshilboum, R. M. Cardiovascular pharmacogenomics and individualized drug therapy. Nat. Rev. Cardiol. 6, 632\u2013638 (2009).","journal-title":"Nat. Rev. Cardiol."},{"key":"284_CR135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1103","volume":"20","author":"M Merlo","year":"2017","unstructured":"Merlo, M. et al. Evolving concepts in dilated cardiomyopathy. Eur. J. Heart Fail. 20, 228\u2013239 (2017).","journal-title":"Eur. J. Heart Fail."},{"key":"284_CR136","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/CIRCULATIONAHA.109.929646","volume":"121","author":"KY Van Spaendonck-Zwarts","year":"2010","unstructured":"Van Spaendonck-Zwarts, K. Y. et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 121, 2169\u20132175 (2010).","journal-title":"Circulation"},{"key":"284_CR137","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1136\/heartjnl-2011-300349","volume":"97","author":"LA Blauwet","year":"2011","unstructured":"Blauwet, L. A. & Cooper, L. T. Diagnosis and management of peripartum cardiomyopathy. Heart 97, 1970\u20131981 (2011).","journal-title":"Heart"},{"key":"284_CR138","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2217\/pgs-2018-0124","volume":"19","author":"E Scott","year":"2018","unstructured":"Scott, E., Hasbullah, J. S., Ross, C. J. & Carleton, B. C. Reducing anthracycline-induced cardiotoxicity through pharmacogenetics. Pharmacogenomics 19, 1147\u20131150 (2018).","journal-title":"Pharmacogenomics"},{"key":"284_CR139","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jacc.2015.07.023","volume":"66","author":"MR Hazebroek","year":"2015","unstructured":"Hazebroek, M. R. et al. Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy applying the MOGE(S) classification. J. Am. Coll. Cardiol. 66, 1313\u20131323 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"284_CR140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41374-018-0104-x","volume":"99","author":"ME Pepin","year":"2018","unstructured":"Pepin, M. E. et al. Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure. Lab. Invest. 99, 371\u2013386 (2018).","journal-title":"Lab. Invest."},{"key":"284_CR141","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10897-017-0200-x","volume":"27","author":"HA Zierhut","year":"2018","unstructured":"Zierhut, H. A., MacFarlane, I. M., Ahmed, Z. & Davies, J. Genetic counselors\u2019 experiences and interest in telegenetics and remote counseling. J. Genet. Couns. 27, 329\u2013338 (2018).","journal-title":"J. Genet. Couns."},{"key":"284_CR142","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fgene.2018.00550","volume":"9","author":"L Du","year":"2018","unstructured":"Du, L. & Becher, S. I. Genetic and genomic consultation: are we ready for direct-to-consumer telegenetics? Front. Genet. 9, 550 (2018).","journal-title":"Front. Genet."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41569-019-0284-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41569-019-0284-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41569-019-0284-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:24:11Z","timestamp":1684607051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-019-0284-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":142,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["284"],"URL":"https:\/\/doi.org\/10.1038\/s41569-019-0284-0","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"assertion":[{"value":"12 September 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}